159 related articles for article (PubMed ID: 8438357)
1. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.
Xia W; Fearon DT; Kirkman RL
Transplant Proc; 1993 Feb; 25(1 Pt 1):410-1. PubMed ID: 8438357
[No Abstract] [Full Text] [Related]
2. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1.
Xia W; Fearon DT; Moore FD; Schoen FJ; Ortiz F; Kirkman RL
Transplant Proc; 1992 Apr; 24(2):479-80. PubMed ID: 1566395
[No Abstract] [Full Text] [Related]
3. Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection.
Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
Transplant Proc; 1992 Apr; 24(2):477-8. PubMed ID: 1566394
[No Abstract] [Full Text] [Related]
4. C1-Inh and heparan sulfate can prevent discordant rejection.
Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
[No Abstract] [Full Text] [Related]
5. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
Candinas D; Bach FH; Hancock WW
Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
[No Abstract] [Full Text] [Related]
6. Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy.
Fujiwara I; Nakajima H; Arakawa K; Akioka K; Takeshita K; Oka T
Transplant Proc; 1996 Apr; 28(2):685-6. PubMed ID: 8623345
[No Abstract] [Full Text] [Related]
7. The effect of MX-1 on survival of discordant cardiac xenografts from guinea pig to rat.
Kaji H; Platt JL; Sutherland DE; Inoue K; Mori C; Shiota K; Imamura M
Transpl Immunol; 1997 Mar; 5(1):70-2. PubMed ID: 9106338
[No Abstract] [Full Text] [Related]
8. Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation.
Candinas D; Lesnikoski BA; Robson SC; Scesney SM; Otsu I; Myiatake T; Marsh HC; Ryan US; Hancock WW; Bach FH
Transplant Proc; 1996 Apr; 28(2):581. PubMed ID: 8623282
[No Abstract] [Full Text] [Related]
9. Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18.
Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
Transplant Proc; 1994 Jun; 26(3):1251. PubMed ID: 7913260
[No Abstract] [Full Text] [Related]
10. Inactivation of C3 and C5 prolongs cardiac xenograft survival and decreases leukocyte infiltration in a model of delayed xenograft rejection.
Johnson EM; Leventhal J; Dalmasso AP; Goswitz J; Simone P; Chen S; Matas AJ
Transplant Proc; 1996 Apr; 28(2):603. PubMed ID: 8623296
[No Abstract] [Full Text] [Related]
11. Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival.
Blakely ML; Van der Werf WJ; Stuhlmeier K; Dalmasso AP; Winkler H; Bach FH
Transplant Proc; 1994 Jun; 26(3):1176. PubMed ID: 7518108
[No Abstract] [Full Text] [Related]
12. Prolonged survival of cardiac xenografts between widely divergent species: bird to mammal.
Braidley PC; Wallwork J; White DJ
Transplant Proc; 1995 Feb; 27(1):307-8. PubMed ID: 7879013
[No Abstract] [Full Text] [Related]
13. Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation.
Kemp E; Dieperink H; Leth P; Jensenius JC; Nielsen B; Lillevang ST; Salomon S; Steinbrüchel D; Larsen S; Koch C
Transplant Proc; 1994 Apr; 26(2):1011-5. PubMed ID: 8171451
[No Abstract] [Full Text] [Related]
14. Rejection and accommodation in the hamster-to-rat heart transplantation model.
Bouwman E; Scheringa M; Nio D; IJzermans JN; Marquet RL
Transplant Proc; 1994 Apr; 26(2):992-3. PubMed ID: 8171723
[No Abstract] [Full Text] [Related]
15. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs.
Braidley PC; Dunning JJ; Wallwork J; White DJ
Transplant Proc; 1994 Jun; 26(3):1259-60. PubMed ID: 8029901
[No Abstract] [Full Text] [Related]
16. Delayed rejection of liver xenografts compared to heart xenografts in the rat.
Settaf A; Meriggi F; Van de Stadt J; Gane P; Crougneau S; Reynes M; Rouger P; Houssin D
Transplant Proc; 1987 Feb; 19(1 Pt 2):1155-7. PubMed ID: 3274299
[No Abstract] [Full Text] [Related]
17. Mechanisms of protection from humoral rejection by a xenografted liver.
Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
[No Abstract] [Full Text] [Related]
18. The role of C3a and C5a in hyperacute rejection of guinea pig-to-rat cardiac xenografts.
Pruitt SK; Baldwin WM; Sanfilippo F
Transplant Proc; 1996 Apr; 28(2):596. PubMed ID: 8623292
[No Abstract] [Full Text] [Related]
19. Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection.
O'Hair DP; Roza AM; Pieper GM; Komorowski R; Moore G; McManus RP; Adams MB
Transplant Proc; 1992 Apr; 24(2):702-3. PubMed ID: 1566490
[No Abstract] [Full Text] [Related]
20. Rat strain differences in complement activity correlate with hyperacute rejection of guinea pig cardiac xenografts.
Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
Transplant Proc; 1993 Oct; 25(5):2848-9. PubMed ID: 8212257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
